List view / Grid view
10 June 2015 | By Victoria White
Bristol-Myers Squibb has announced that data from the Orencia Phase 3b AVERT and AMPLE trials will be presented in during the EULAR 2015...
10 June 2015 | By Victoria White
Bayer has entered into a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd., for EUR 1,022 million...
10 June 2015 | By Victoria White
The FDA has granted Breakthrough Therapy designation status to Roche’s ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc)...
10 June 2015 | By Victoria White
Data presented at EULAR 2015 show that the effectiveness of Celltrion’s biosimilar infliximab was similar to the RMP in rheumatoid arthritis...
10 June 2015 | By Victoria White
UBM EMEA, organiser of CPhI South East Asia and CPhI Japan, has celebrated the closing of two growing Asian events that took place in April this year...
9 June 2015 | By GE
At the ACHEMA 2015 trade show in Frankfurt, GE showcases applications for use in Asset Performance Management (APM) in the chemical and process industries...
9 June 2015 | By Coulter Partners
Coulter Partners is pleased to announce the appointment of Shawn O’Connor as a Managing Director of their US business...
9 June 2015 | By NICE
NICE has recommended the anti-blood clotting drug apixaban as an option for treating and preventing venous thromboembolism (VTE) in adults...
9 June 2015 | By Victoria White
Carbylan Therapeutics has completed enrollment of its COR1.1 Phase 3 pivotal trial of Hydros-TA for the treatment of pain associated with osteoarthritis...
9 June 2015 | By Victoria White
Johnson & Johnson and a group of leading research organisations are launching the OPTICS Project - Open Translational Science in Schizophrenia...
9 June 2015 | By Victoria White
UBM EMEA announced the findings of the Pharma Insights Turkey 2015 report, a comprehensive review of the Turkish pharma market, at CPhI Istanbul...
9 June 2015 | By Victoria White
Results of the ELIXA study assessing the cardiovascular safety of lixisenatide in adults with type 2 diabetes and high CV risk have been presented...
9 June 2015 | By Victoria White
Cost-containment measures are shifting the decision-making focus of North America’s pharmaceutical market from the prescriber to the payer, says GlobalData...
9 June 2015 | By Victoria White
Lenvima launches in the UK today as a treatment option for people with radioactive iodine refractory differentiated thyroid cancer (RAI refractory DTC)...
8 June 2015 | By Victoria White
BioMarin has submitted a MAA for drisapersen for the treatment of the largest subset of Duchenne muscular dystrophy (DMD) amenable to single exon skipping...
